Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 210

1.

Pharmacoeconomic evaluation of clozapine in treatment-resistant schizophrenia: a cost-utility analysis.

Oh PI, Iskedjian M, Addis A, Lanctôt K, Einarson TR.

Can J Clin Pharmacol. 2001 Winter;8(4):199-206.

PMID:
11743592
[PubMed - indexed for MEDLINE]
2.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
[PubMed - indexed for MEDLINE]
3.

Cost-effectiveness of clozapine compared with conventional antipsychotic medication for patients in state hospitals.

Essock SM, Frisman LK, Covell NH, Hargreaves WA.

Arch Gen Psychiatry. 2000 Oct;57(10):987-94.

PMID:
11015817
[PubMed - indexed for MEDLINE]
4.

A cost-effectiveness clinical decision analysis model for schizophrenia.

Palmer CS, Revicki DA, Genduso LA, Hamilton SH, Brown RE.

Am J Manag Care. 1998 Mar;4(3):345-55.

PMID:
10178497
[PubMed - indexed for MEDLINE]
Free Article
5.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

PMID:
16707074
[PubMed - indexed for MEDLINE]
Free Article
6.

Pharmacogenetic testing in the clinical management of schizophrenia: a decision-analytic model.

Perlis RH, Ganz DA, Avorn J, Schneeweiss S, Glynn RJ, Smoller JW, Wang PS.

J Clin Psychopharmacol. 2005 Oct;25(5):427-34.

PMID:
16160617
[PubMed - indexed for MEDLINE]
7.

A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.

Rosenheck R, Cramer J, Xu W, Thomas J, Henderson W, Frisman L, Fye C, Charney D.

N Engl J Med. 1997 Sep 18;337(12):809-15.

PMID:
9295240
[PubMed - indexed for MEDLINE]
Free Article
8.

Costs and effects of long-acting risperidone compared with oral atypical and conventional depot formulations in Germany.

Laux G, Heeg B, van Hout BA, Mehnert A.

Pharmacoeconomics. 2005;23 Suppl 1:49-61.

PMID:
16416761
[PubMed - indexed for MEDLINE]
9.

Pharmacoeconomic evaluation of treatments for refractory schizophrenia: clozapine-related studies.

Revicki DA.

J Clin Psychiatry. 1999;60 Suppl 1:7-11; discussion 28-30. Review.

PMID:
10037164
[PubMed - indexed for MEDLINE]
10.

Risperidone versus haloperidol: II. Cost-effectiveness.

Davies A, Langley PC, Keks NA, Catts SV, Lambert T, Schweitzer I.

Clin Ther. 1998 Jan-Feb;20(1):196-213.

PMID:
9522115
[PubMed - indexed for MEDLINE]
11.

Multiple outcome assessment in a study of the cost-effectiveness of clozapine in the treatment of refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.

Rosenheck R, Cramer J, Xu W, Grabowski J, Douyon R, Thomas J, Henderson W, Charney D.

Health Serv Res. 1998 Dec;33(5 Pt 1):1237-61.

PMID:
9865219
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Long-acting risperidone compared with oral olanzapine and haloperidol depot in schizophrenia: a Belgian cost-effectiveness analysis.

De Graeve D, Smet A, Mehnert A, Caleo S, Miadi-Fargier H, Mosqueda GJ, Lecompte D, Peuskens J.

Pharmacoeconomics. 2005;23 Suppl 1:35-47.

PMID:
16416760
[PubMed - indexed for MEDLINE]
13.

Changing environments and alternative perspectives in evaluating the cost-effectiveness of new antipsychotic drugs.

Rosenheck R, Doyle J, Leslie D, Fontana A.

Schizophr Bull. 2003;29(1):81-93.

PMID:
12908663
[PubMed - indexed for MEDLINE]
Free Article
14.

Risperidone. A pharmacoeconomic review of its use in schizophrenia.

Foster RH, Goa KL.

Pharmacoeconomics. 1998 Jul;14(1):97-133. Review.

PMID:
10182198
[PubMed - indexed for MEDLINE]
15.

Cost-utility analysis of treatment with olanzapine compared with other antipsychotic treatments in patients with schizophrenia in the pan-European SOHO study.

Knapp M, Windmeijer F, Brown J, Kontodimas S, Tzivelekis S, Haro JM, Ratcliffe M, Hong J, Novick D; SOHO Study Group.

Pharmacoeconomics. 2008;26(4):341-58.

PMID:
18370568
[PubMed - indexed for MEDLINE]
16.

Pharmacoeconomic studies of atypical antipsychotic drugs for the treatment of schizophrenia.

Revicki DA.

Schizophr Res. 1999 Mar 1;35 Suppl:S101-9. Review.

PMID:
10190231
[PubMed - indexed for MEDLINE]
17.

Cost-effectiveness of clozapine in patients with high and low levels of hospital use. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.

Rosenheck R, Cramer J, Allan E, Erdos J, Frisman LK, Xu W, Thomas J, Henderson W, Charney D.

Arch Gen Psychiatry. 1999 Jun;56(6):565-72.

PMID:
10359474
[PubMed - indexed for MEDLINE]
18.

Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies.

Greenhalgh J, Knight C, Hind D, Beverley C, Walters S.

Health Technol Assess. 2005 Mar;9(9):1-156, iii-iv. Review.

PMID:
15774232
[PubMed - indexed for MEDLINE]
Free Article
19.

[Medico-economic study of Léponex (clozapine) in the Bordeaux Charles Perrens Hospital Center].

Bret P, Jolivel C, Bret MC, Veylit S, Martin C, Garcia P.

Encephale. 1998 Jul-Aug;24(4):365-77. French.

PMID:
9809242
[PubMed - indexed for MEDLINE]
20.

Assessing cost-effectiveness of drug interventions for schizophrenia.

Magnus A, Carr V, Mihalopoulos C, Carter R, Vos T.

Aust N Z J Psychiatry. 2005 Jan-Feb;39(1-2):44-54.

PMID:
15660705
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk